All terms in ADO

Label Id Description
down-regulation INO_0000093 [a negative regulation that one interactor down-regulates another.]
clinical trial phase 4 CTO_0000206 [A clinical trial phase that is designed for a randomized, controlled trial to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed. [def-source: NCI]]
PRKAA2 OGG_3000005563
clinical trial phase 3 CTO_0000205 [A clinical trial phase that is designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo. [def-source: NCI]]
ICAM1 OGG_3000003383
clinical trial phase 2 CTO_0000204 [A clinical trial phase that is designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention. [def-source: NCI]]
clinical trial phase 1 CTO_0000203 [A clinical trial phase that represents the first-in-man trial, which tests within a small group of people (typically 20-80) to evaluate safety, determine safe dosage ranges, and begin to identify side effects. A drug's side effects could be subtle or long term, or may only happen with a few people, so phase 1 trials are not expected to identify all side effects.]
APH1B OGG_3000083464
estrogen CHEBI_50114 [A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.]
psychotic disorder DOID_2468 [A cognitive disorder that involves abnormal thinking and perceptions resulting in a disconnection with reality.]
glucose transmembrane transport GO_1904659 [The process in which glucose is transported across a membrane.]
Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology MONDO_0011513
HSPA5 OGG_3000003309
HSPA1B OGG_3000003304
brainstem UBERON_0002298 [Multi-tissue structure that has as its parts the medulla oblongata of the hindbrain and the tegmentum of the midbrain[ZFA,adopted][ZFA:0001707]., Stalk-like part of the brain that includes amongst its parts the medulla oblongata of the hindbrain and the tegmentum of the midbrain[ZFA,MP,generalized]., the stalk-like part of the brain that comprises the midbrain (aka mesencephalon), the pons (aka pons Varolii), and the medulla oblongata, and connects the cerebral hemispheres with the cervical spinal cord[MP], Multi-tissue structure that has as its parts the medulla oblongata of the hindbrain and the tegmentum of the midbrain.[TAO]]
STXBP1 OGG_3000006812
CHRM1 OGG_3000001128
SUOX OGG_3000006821
Blinded Clinical Study NCIT_C70840 [A clinical study that is designed using a procedure in which one or more parties to the study [subject(s), investigator(s), monitor, or/and data analyst(s)] are kept unaware of the treatment assignment(s).]
Clinical Study NCIT_C15206 [Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.]